Clinical Trials Directory

Trials / Completed

CompletedNCT07046325

Comparison Between Dexametidomedine\Bupivacaine and Plain Bupivacaine in Superior Trunk Block for Arthroscopic Shoulder Surgeries

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Comparison between dexametidomedine\\bupivacaine and plain bupivacaine in superior trunk block for arthroscopic shoulder surgeries

Detailed description

This study will be conducted to investigate the efficacy of adding dexmedetomidine in STB for postoperative analgesia in patients undergoing arthroscopic shoulder surgery. * Inclusion Criteria: 1. age ;20-50 years old of both genders 2. American Society of Anesthesiologists physical status I and II 3. BMI less than 30 4. Arthroscopic shoulder surgeries. * Exclusion Criteria: 1. Patients with ASA more than II 2. Patients with a sepsis, malignancy anywhere 3. Patient with bleeding tendencies or on anticoagulation therapy 4. Patients with pre-existing neurologic deficit or neuropathy affecting brachial plexus 5. Allergy to study drugs. Study groups: The patients will be randomized into 2 groups: 1. Group DB: are administered Ultrasound guided STB with bupivacaine and dexametidomedine. 2. Group B: are administered Ultrasound guided STB with bupivacaine. Primary outcome: Duration of analgesia of Superior trunck block. Secondary outcome: 1. Cumulative dose of postoperative consumption of the rescue analgesia during 24h after STB 2. Durations of motor blockade (DOM) 3. Residual block related neurological symptoms 4. Hemodynamic variables 5. Dyspnea and sedation scale.

Conditions

Interventions

TypeNameDescription
DRUGdexametedomidine1\. Group DB: are administered Ultrasound guided STB with bupivacaine and dexametidomedine.
DRUGBupivacain2\. Group B: are administered Ultrasound guided STB with bupivacaine.

Timeline

Start date
2025-01-20
Primary completion
2025-04-20
Completion
2025-05-01
First posted
2025-07-01
Last updated
2025-07-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07046325. Inclusion in this directory is not an endorsement.